Received Jun 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Priorix and possible diluent only administration; Priorix and possible diluent only administration; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received MMR (Priorix) for prophylaxis. On an unknown date, the patient received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced inappropriate preparation of medication (Verbatim: Priorix and possible diluent only administration) and inappropriate dose of vaccine administered (Verbatim: Priorix and possible diluent only administration). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 29-MAY-2025 Pharmacist calls to report suspects the diluent only of the Priorix vaccine was administered to a patient because has 1 vial of the lyophilized portion left with no diluent which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. States has no further information or patient details at the moment of call. The Vaccine Administration Facility is the same as Primary Reporter. The adverse event details were asked and declined because were not available at the moment of call.